Mar Mallo

10PUBLICATIONS

88CO-AUTHORS

Predictive and prognostic markersSolid tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 10, 2026

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Sep 27, 2025

A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing.

Alejandra Mosteiro, Diouldé Diao, Carmen Bedia

|Feb 13, 2025

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Ana Maria Muñoz-Mármol, Bárbara Meléndez, Ainhoa Hernandez

|Feb 24, 2024

The C250T Mutation of <i>TERTp</i> Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Teresa Gorria, Carme Crous, Estela Pineda

|May 19, 2023

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype.

Mar Mallo, Heinz Tuechler, Leonor Arenillas

|Apr 14, 2022

CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.

Clara Bueno, Susana Barrera, Alex Bataller

Pageof 2

Frequent Collaborators

Estela Pineda

Francesc Solé

Sira Domenech

Iban Aldecoa

Anna Esteve

Anna Esteve-Codina

Maria Martinez-García

2 joint publications

Oscar Gallego

2 joint publications

Ana Maria Muñoz-Marmol

2 joint publications

Beatriz Bellosillo

Frequent Collaborators

Estela Pineda

Francesc Solé

Sira Domenech

Iban Aldecoa